- Home
- ODD vs OPK Comparison
ODD vs OPK Comparison
Compare ODD & OPK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ODD | OPK |
|---|---|---|
| Founded | 2018 | 2006 |
| Country | Israel | United States |
| Employees | 658 | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 783.3M | 921.2M |
| IPO Year | 2022 | 2011 |
Fundamental Metrics
Financial Performance| Metric | ODD | OPK |
|---|---|---|
| Price | $14.34 | $1.15 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 11 | 5 |
| Target Price | ★ $41.00 | $2.03 |
| AVG Volume (30 Days) | 1.5M | ★ 2.5M |
| Earning Date | 04-28-2026 | 04-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $606,879,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $22.92 | $4.24 |
| P/E Ratio | $16.73 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $10.80 | $1.10 |
| 52 Week High | $79.18 | $1.60 |
Technical Indicators
Market Signals| Indicator | ODD | OPK |
|---|---|---|
| Relative Strength Index (RSI) | 42.65 | 47.51 |
| Support Level | $12.53 | $1.12 |
| Resistance Level | $14.80 | $1.27 |
| Average True Range (ATR) | 0.84 | 0.04 |
| MACD | 0.63 | 0.01 |
| Stochastic Oscillator | 53.07 | 48.00 |
Price Performance
Historical ComparisonAbout ODD ODDITY Tech Ltd.
ODDITY Tech Ltd offers a consumer tech platform that is built to transform the beauty and wellness market. The ODDITY platform is designed to support a portfolio of brands and services that innovate and disrupt the expansive beauty and wellness market. It consumes user data to develop physical beauty and wellness products that deliver performance and functionality. Its brands include SpoiledChild and IL Makiage. Geographically, the company generates majority revenue from United states followed by other countries and Israel.
About OPK OPKO Health Inc.
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.